Related posts: Overview of Current Diabetes Management Organization of Diabetes Care Sodium-glucose Cotransporter-2 Inhibitors Epidemiology and Pathogenesis of Type 2 Diabetes Dipeptidyl Peptidase-4 Inhibitors The Incretin Mimetics
Related posts: The Incretin System Organization of Diabetes Care Sodium-glucose Cotransporter-2 Inhibitors Epidemiology and Pathogenesis of Type 2 Diabetes Dipeptidyl Peptidase-4 Inhibitors The Incretin Mimetics
CHAPTER 4 REDUCING CARDIOVASCULAR RISK Understanding cardiovascular risk 86 Raised blood pressure 91 Dyslipidaemia 109 Obesity 121 Reducing platelet adhesiveness 125 Other risk factors 127 An “Alternative” view of targets…
CHAPTER 7 THE ORGANISATION AND DELIVERY OF OPTIMAL DIABETES CARE Background to the changing organisation of diabetes services 186 Components of optimal organisation within primary care 189 Delivering high-quality care…
CHAPTER 5 DIABETES COMPLICATIONS Eyes 134 Nephropathy 138 Feet 143 Neuropathy 151 Erectile dysfunction 155 Injection sites 160 Vascular emergencies 160 OVERVIEW NSF 11 12 In this section, specific complications…
CHAPTER 3 GLYCAEMIC CONTROL Monitoring 62 Blood glucose-lowering medication 65 Metabolic emergencies 82 OVERVIEW NSF 4 QOF DM5–7 To achieve and maintain the targets (Table 3.1) of optimal glycaemic control…
CHAPTER 6 LIVING WITH DIABETES Mental health 164 Driving 165 Immunisations 167 Employment 167 Intercurrent illness 169 Travel 169 Pregnancy and gestational diabetes 172 Cultural aspects of diabetes care 176…
CHAPTER 1 WHAT IS TYPE 2 DIABETES MELLITUS? Definition of diabetes mellitus 6 Classification of diabetes mellitus 6 Criteria and methods for the diagnosis of diabetes mellitus 8 Disease processes…
